Dmitry Balyasny’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Dmitry Balyasny’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-402,364	Closed	-$24.2M	–	2643
2021 Q1	$24.2M	Buy	+402,364	New	+$14.6M	0.12%	228

Dmitry Balyasny's PAND Position: Q2 2021 in Review

Dmitry Balyasny sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 402,364 shares — an estimated $24.2M sold.

Dmitry Balyasny first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $24.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Dmitry Balyasny reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Dmitry Balyasny sold 402,364 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $24.2M.
Dmitry Balyasny first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Dmitry Balyasny's Pandion Therapeutics Inc. Common Stock position peaked at $24.2M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.